Emma S. Scott - Search Results

Year	Number of Results
2017	2
2018	2
2019	1
2020	2
2021	2
2024	0

1

Challenges of diabetes management during the COVID-19 pandemic.

Scott ES, Jenkins AJ, Fulcher GR. Scott ES, et al. Med J Aust. 2020 Jul;213(2):56-57.e1. doi: 10.5694/mja2.50665. Epub 2020 Jun 24. Med J Aust. 2020. PMID: 32583422 No abstract available.

2

Insulin micro-secretion in Type 1 diabetes and related microRNA profiles.

Januszewski AS, Cho YH, Joglekar MV, Farr RJ, Scott ES, Wong WKM, Carroll LM, Loh YW, Benitez-Aguirre PZ, Keech AC, O'Neal DN, Craig ME, Hardikar AA, Donaghue KC, Jenkins AJ. Januszewski AS, et al. Among authors: scott es. Sci Rep. 2021 Jun 3;11(1):11727. doi: 10.1038/s41598-021-90856-6. Sci Rep. 2021. PMID: 34083567 Free PMC article.

3

Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes.

Scott ES, Januszewski AS, Carroll LM, Fulcher GR, Joglekar MV, Hardikar AA, Jones TW, Davis EA, Jenkins AJ. Scott ES, et al. Sci Rep. 2021 Aug 17;11(1):16656. doi: 10.1038/s41598-021-95824-8. Sci Rep. 2021. PMID: 34404828 Free PMC article.

4

Association Between Glycemic Variability, HbA_1c, and Large-for-Gestational-Age Neonates in Women With Type 1 Diabetes.

McGrath RT, Glastras SJ, Seeho SK, Scott ES, Fulcher GR, Hocking SL. McGrath RT, et al. Among authors: scott es. Diabetes Care. 2017 Aug;40(8):e98-e100. doi: 10.2337/dc17-0626. Epub 2017 Jun 14. Diabetes Care. 2017. PMID: 28615243 No abstract available.

5

Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.

Scott ES, Januszewski AS, O'Connell R, Fulcher G, Scott R, Kesaniemi A, Wu L, Colagiuri S, Keech A, Jenkins AJ. Scott ES, et al. J Clin Endocrinol Metab. 2020 Oct 1;105(10):dgaa361. doi: 10.1210/clinem/dgaa361. J Clin Endocrinol Metab. 2020. PMID: 32766757

6

Outcomes for Women with Gestational Diabetes Treated with Metformin: A Retrospective, Case-Control Study.

McGrath RT, Glastras SJ, Scott ES, Hocking SL, Fulcher GR. McGrath RT, et al. Among authors: scott es. J Clin Med. 2018 Mar 9;7(3):50. doi: 10.3390/jcm7030050. J Clin Med. 2018. PMID: 29522471 Free PMC article.

7

The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma.

Scott ES, Long GV, Guminski A, Clifton-Bligh RJ, Menzies AM, Tsang VH. Scott ES, et al. Eur J Endocrinol. 2018 Feb;178(2):173-180. doi: 10.1530/EJE-17-0810. Epub 2017 Nov 29. Eur J Endocrinol. 2018. PMID: 29187509

8

HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment.

Scott ES, McGrath RT, Januszewski AS, Calandro D, Hardikar AA, O'Neal DN, Fulcher G, Jenkins AJ. Scott ES, et al. BMJ Open. 2019 Dec 29;9(12):e033059. doi: 10.1136/bmjopen-2019-033059. BMJ Open. 2019. PMID: 31888933 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year